Staple-line recurrence arising 10 years after functional end-to-end anastomosis for colon cancer: a case report by Akira Ouchi et al.
Ouchi et al. Surgical Case Reports  (2015) 1:7 
DOI 10.1186/s40792-014-0011-3REPORT Open AccessStaple-line recurrence arising 10 years after
functional end-to-end anastomosis for colon
cancer: a case report
Akira Ouchi*, Masahiko Asano, Keiya Aono, Tetsuya Watanabe and Shingo OyaAbstract
We report a rare case of late staple-line recurrence arising 10 years after functional end-to-end anastomosis for
splenic flexure colon cancer. An 80-year-old man, who underwent partial colectomy with functional end-to-end
anastomosis for splenic flexure colon cancer 10 years earlier, presented with a chief complaint of anorexia.
Complete blood count showed anemia, and the fecal occult blood test was positive. Lower gastrointestinal series
showed an irregular defect of the splenic flexure, and colonoscopy showed an ulcerated tumor on the staple line
of the primary surgery. Partial colectomy was performed, and the tumor was pathologically diagnosed as moderately
differentiated tubular adenocarcinoma, resembling the pathology of primary colon cancer. This case suggests the
importance of considering staple-line recurrence after functional end-to-end anastomosis for colon cancer even
more than 5 years after primary surgery.
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Mechanically stapled anastomosis (MSA) is a widely used
technique in various digestive surgeries, and functional
end-to-end anastomosis (FEEA) is often used in lower
gastrointestinal surgeries. Several studies have reported
that FEEA commensurates the surgical technique of
surgeons and decreases anastomotic leakage, the risk of
surgical site infection, and the surgery time [1,2]. FEEA
is an easy and safe technique compared with conventional
hand-sewn anastomosis; and in recent years, it has been
used by many surgeons for reconstruction after a lower
gastrointestinal surgery.
Meanwhile, it is presumed that FEEA occasionally causes
staple-line recurrence, which is due to the implantation of
free intraluminal cancer cells [3]. Staple-line recurrence
occurs few years after primary surgery, and careful follow-
up is required during this period. We report a rare case of
late staple-line recurrence arising 10 years after FEEA for
splenic flexure colon cancer. This case report highlights
the importance of considering staple-line recurrence* Correspondence: akira.ouc@gmail.com
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cancer.Case presentation
An 80-year-old Japanese male, with a history of hyperten-
sion, had undergone partial colectomy with FEEA using
autosutures (Endo GIA™, Covidien, Ireland) for splenic
flexure colon cancer and distal gastrectomy with hand-
sewn retrocolic Billroth-II gastrojejunostomy 10 years be-
fore. Pathological examination had revealed moderately
differentiated tubular adenocarcinoma with KRAS wild-
type, positive immunohistochemical staining for p53 and
cdx2, negative for CD10 and MUC5AC, invading the sub-
serosa without lymph node metastases. The cancer was
resected with distal and proximal margin of each 10 cm,
and no tumor cells had been identified at the surgical
margins. Carcinoembryonic antigen (CEA) and carbohy-
drate antigen 19–9 (CA 19–9) were within the normal
range. He had been well without any signs of locoregional
recurrence and distant metastases. He had undergone the
latest colonoscopy 7 years before and contrast-enhanced
computed tomography (CECT) 5 years before.
The patient presented to our clinic with a chief com-
plaint of anorexia. He had slight conjunctival pallor, andn Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 2 Colonoscopy showed an ulcerated macroscopic type 2
tumor on the staple line (arrows).
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a low red blood cell count (397 × 104/mL) and a low
hemoglobin count (12.9 g/dL). CEA and CA 19–9 were
within the normal range. We performed a fecal occult
blood test twice, and it was positive on both occasions.
We suspected metachronous colorectal cancer and
performed lower gastrointestinal series and colonoscopy
for further examination. Lower gastrointestinal series
showed an irregular defect of the splenic flexure near
the anastomosis line of the primary surgery (Figure 1),
and colonoscopy showed an ulcerated macroscopic type 2
tumor on the staple line of the primary surgery (Figure 2).
Pathological examination of a biopsy specimen obtained
by colonoscopy revealed moderately differentiated tubu-
lar adenocarcinoma. CECT showed a colon tumor of the
splenic flexure at the staple line, but no distant metasta-
ses were found (Figure 3). The suspicion of staple-line
recurrence after FEEA of the primary surgery was con-
firmed, and we performed open partial colectomy for
radical resection. For reconstruction after partial colec-
tomy, we performed hand-sewn end-to-end colocolost-
omy by the Gambee method using 3–0 Vicryl™ (Ethicon
Endo-surgery; Johnson & Johnson K.K., USA). The sur-
gery time was 159 min, and blood loss was 250 g. A
resected specimen during the surgery contained an ul-
cerated macroscopic type 2 tumor, 4 × 4 cm in diameter,
destructive of crossed staple line (Figure 4). A patho-
logical examination revealed moderately differentiated
tubular adenocarcinoma, invading the subserosa (Figure 5).
The pathology of resected specimen resembled the
pathology of primary colon cancer with KRAS wild-
type, positive immunohistochemical staining for p53
and cdx2 and negative for CD10 and MUC5AC (Figure 6).
We thus finally diagnosed the patient with staple-line
recurrence, arising 10 years after FEEA of the primary
surgery.Figure 1 Lower gastrointestinal series showed an irregular
defect of the splenic flexure (arrows).Although the patient developed symptomatic anasto-
motic leakage (Clavien-Dindo Grade IIIA; [4]), he im-
proved after treatment with percutaneous drainage and
was discharged from the hospital 45 days after the sur-
gery in good health. The patient underwent a colonos-
copy 12 months after the secondary surgery, and the
colonoscopy showed no signs of anastomotic recurrence.
He has remained well without any signs of further recur-
rence at the 15-month follow-up.
Discussion
Locoregional recurrence is the most frequent recurrence
in patients with resected colon cancer apart from liver
metastasis and lung metastasis [5]. Locoregional recur-
rence is classified as either local recurrence or regional re-
currence. Local recurrence is defined as tumor regrowth
at anastomosis or immediately within or contiguous to theFigure 3 Contrast-enhanced computed tomography (CECT)
showed a splenic flexure colon tumor at the staple line (arrows).
Figure 4 A resected specimen contained an ulcerated macroscopic type 2 tumor destructive of crossed staple line.
Figure 5 Pathological examination revealed moderately
differentiated tubular adenocarcinoma (H.E. stain; a × 4, b × 40).
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usually called anastomotic recurrence [6]. The mechanism
of tumor regrowth in anastomotic recurrence is as follows:
free intraluminal cancer cells of colonic origin penetrate
through watertight anastomoses, implant on the anasto-
motic surface, and initiate tumor regrowth [3]. MSA such
as functional end-to-end anastomosis or double stapling
technique (DST) reportedly has a higher risk of anasto-
motic recurrence (in particular, staple-line recurrence)
than hand-sewn anastomosis [7-9]. However, the reason
for the high recurrence rate in MSA is unclear. Intraoper-
ative intestinal irrigation reportedly reduces staple-line re-
currence with DST for rectal cancer and now is widely
performed [10]. In contrast, intraoperative intestinal irri-
gation is not often performed during FEEA for colon can-
cer mainly because of the challenging procedure and the
high risk of surgical field contamination. Hasegawa et al.
reported that surgical bowel occlusion around the tumor
and intraluminal lavage can prevent or eliminate exfoli-
ated malignant cells at anastomotic sites [11], but it is un-
clear whether intraoperative intestinal irrigation in FEEA
for colon cancer decreases staple-line recurrence. Till
date, there are no recommendations on how to decrease
staple-line recurrence with FEEA for colon cancer.
Most postoperative recurrences in patients with resected
colon cancer occur during the first 5 years; especially,
almost all staple-line recurrences occur within the first
3 years after primary surgery [12,13]. In many countries,
the follow-up period in patients with resected colon
cancer is 5 years, similar to Japan [14-16]. There are few
reports on late recurrence, including staple-line recur-
rence, of colon cancer more than 10 years after primary
Figure 6 The pathology of resected specimen (a) resembled the pathology of primary colon cancer (b).
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report on late staple-line recurrence arising 10 years
after FEEA for colon cancer.
Colonoscopy is useful for finding staple-line recurrence
after FEEA for colon cancer, and it is recommended for
surveillance in patients with resected colon cancer in
addition to history taking, physical examination, CEA
measurement, and CECT scan in several guidelines
[14-16]. For example, NCCN clinical practice guidelines
for colon cancer suggest that patients with resected
colon cancer should undergo colonoscopy 1 year after
primary surgery and the subsequent examination is rec-
ommended 3 years from first examination, if normal,
and the third examination 5 years from the second
examination, if normal. Colonoscopy at this stage, how-
ever, is not performed for the detection of locoregional
recurrence of primary cancer, enabling curative treatment,
but it is performed for the detection of metachronous
colorectal cancer [17]. Several randomized controlled tri-
als of intensive surveillance with colonoscopy and meta-
analyses of these trials have shown no survival benefit
from primary cancer by performing colonoscopy at annual
or shorter intervals; therefore, the goal of surveillance with
colonoscopy in patients with resected colon cancer is to
detect metachronous colorectal cancer at an early stage
[18-23]. Routine colonoscopy is not appropriate in all pa-
tients with resected colon cancer to detect staple-line recur-
rence after FEEA considering the relatively low incidence of
staple-line recurrence in colon cancer. To detect staple-line
recurrence after FEEA, careful work-ups must be per-
formed only on patients with a history of resected colon
cancer who complain of any digestive organ symptoms.
Conclusions
Our case suggests the possibility of late staple-line recur-
rence after FEEA for colon cancer even more than 5 yearsafter primary surgery. Consideration of staple-line recur-
rence and careful work-up is important when patients
with FEEA for colon cancer complain of any digestive
organ symptoms.
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